血液透析患者丙型肝炎病毒感染的特点及防治
被引量:3
摘要
1流行病学丙型肝炎病毒(hepatitis C virus,HCV)为一种单链RNA病毒,直径50~60nm,大约由9400个核苷酸组成。近似于人类黄热病病毒[1]。HCV的传播途径主要是输血和血液制品,性接触,经胎盘垂直传播的机会很少。与乙肝病毒相比,
出处
《中国血液净化》
2012年第8期409-412,共4页
Chinese Journal of Blood Purification
参考文献24
-
1张小丽,朱蓓,喻荣彬,赵卫红.血液透析人群丙型肝炎病毒感染的多中心临床研究[J].中国血液净化,2011,10(8):429-432. 被引量:12
-
2汪年松,盛晓华,张晓光,严艳,俞岗,崔勇平,唐令诠.维持性血液透析患者感染丙型病毒性肝炎126个月随访研究[J].中国血液净化,2009,8(11):593-596. 被引量:15
-
3曹娅丽,王世相,郭苹,刘航.维持性血液透析患者丙型肝炎病毒感染的预防与预后观察[J].中国血液净化,2006,5(8):430-432. 被引量:15
-
4Okamoto H,Okatla S,Sugiyama Y,et al.The5terminalsequence of hepatitis C virus genomeJpn J Exp,1997.
-
5El-Sherif A,Elbahrawy A,Aboelfotoh A,et al.High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysisHemodial Int,2012.
-
6Fabrizi F,Dulai G,Dixit V,Bunnapradist S,Martin P.Interferon for the treatment of chronic hepatitis C in dialysis patientsAlimentary Pharmacology and Therapeutics,2003.
-
7Cooper CL,Druyts E,Thorlund K,et al.Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype1infection:an indirect comparison meta-analysisTher Clin Risk Manag,2012.
-
8Tsui JI,Vittinghoff E,Shlipak MG,O’Hare AM.Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination SurveyJournal of the American Society of Nephrology,2006.
-
9J.I. Tsui,E. Vittinghoff,M.G. Shlipak.Association of hepatitis C seropositivity with increased risk for developing end-stage renal diseaseArchives of Internal Medicine,2007.
-
10Espinosa,M,Martin-Malo,A,de,Alvarez Lara,MA,Aljama,P.Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patientsNephrology Dialysis Transplantation,2001.
二级参考文献33
-
1丙型肝炎防治指南[J].中华内科杂志,2004,43(7):551-555. 被引量:106
-
2王迪,张雪,杨复华,李文鑫.丙型肝炎病毒蛋白的分子生物学研究进展[J].中国病毒学,2004,19(5):526-530. 被引量:12
-
3孟建中.关注透析患者肝炎病毒重叠感染的问题[J].中国血液净化,2004,3(12):672-674. 被引量:9
-
4无.慢性乙型肝炎防治指南[J].实用肝脏病杂志,2006,9(1):8-18. 被引量:825
-
5曹娅丽,王世相,郭苹,刘航.维持性血液透析患者丙型肝炎病毒感染的预防与预后观察[J].中国血液净化,2006,5(8):430-432. 被引量:15
-
6王银娜,刘惠兰,刘群.血清肝细胞生长因子与维持性血液透析患者动脉粥样硬化的相关性研究[J].中国血液净化,2006,5(10):714-716. 被引量:3
-
7Patel PR, Thompson ND, Kallen AJ, et al. Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients[J]. Am J Kidney Dis, 2010,56:371- 378.
-
8Kumagai J, Komiya Y, Tanaka J, et al. Hepatitis C virus infection in 2,744 hemodialysis patients followed regularly at nine centers in Hiroshima during November 1999 through February 2003[J]. J Med Virol, 2005, 76:498-502.
-
9Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, et al. Hepatitis C virus and death risk in hemodialysis patients [J]. J Am Soc Nephrol, 2007,18:1584-1593.
-
10Jasuja S, Gupta AK, Choudhry R, et al. Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital[J]. Indian J Nephrol, 2009,19: 62-67.
共引文献40
-
1孙婷.血透室医务人员职业暴露情况分析[J].医学信息(医学与计算机应用),2014,0(24):574-574.
-
2王文健,梁馨苓,史伟.隔离管理丙型肝炎病毒阳性透析患者的指南与政策的分歧[J].中国血液净化,2012,11(8):407-408. 被引量:1
-
3Tatsuo Kanda,Keizo Kato,Akihito Tsubota,Nobuo Takada,Takayoshi Nishino,Shigeru Mikami,Tatsuo Miyamura,Daisuke Maruoka,Shuang Wu,Shingo Nakamoto,Makoto Arai,Keiichi Fujiwara,Fumio Imazeki,Osamu Yokosuka.Platelet count and sustained virological response in hepatitis C treatment[J].World Journal of Hepatology,2013,5(4):182-188.
-
4Jing Yuan,Yi Yang, Fei Han, Ping Zhang, Xiao-Ying Du, Hua Jiang and Jiang-Hua Chen The Kidney Disease Center, First Affiliated Hospital, Zhejiang University School of Medicine (Yuan J, Yang Y, Han F, Zhang P, Du XY, Jiang H and Chen JH),and Hemodialysis Quality Control Center of Zhejiang Province (Yuan J, Zhang P, Du XY and Chen JH), Hangzhou 310003, China.Quality control measures for lowering the seroconversion rate of hemodialysis patients with hepatitis B or C virus[J].Hepatobiliary & Pancreatic Diseases International,2012,11(3):302-306. 被引量:2
-
5赵华,常明,刑淑巧.血液透析患者肝炎病毒感染情况分析[J].中国血液净化,2008,7(4):207-209. 被引量:15
-
6杨慧芳,俞建芬,张娟.血液透析患者乙肝、丙肝感染现状分析与护理体会[J].实用医学杂志,2008,24(11):2002-2003. 被引量:6
-
7杨慧芳,俞建芬,张娟.血液透析患者乙肝、丙肝感染现状调查[J].福州总医院学报,2008,15(2):105-106. 被引量:1
-
8盛晓华,汪年松.维持性血液透析患者感染丙型病毒性肝炎的传播途径[J].中国血液净化,2009,8(11):590-592. 被引量:10
-
9李六亿.血液透析感染丙型肝炎事件引发的思考[J].中国护理管理,2010,10(4):36-39. 被引量:12
-
10曹红梅.血透室护士受血源性传播疾病的危害和对策[J].护理实践与研究,2010,7(17):73-74.
同被引文献23
-
1魏来.亚太地区丙型肝炎病毒感染的诊断、处理和治疗共识[J].临床肝胆病杂志,2007,23(5):323-327. 被引量:11
-
2Zahedi M], Darvish Moghaddam S, Alavian SM, et aL Se-: roprevalence of Hepatitis Viruses B, G, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran[]]. Hepat Mon, 2012, 12:339-343,.
-
3Fontenele AM, Fi lho NS, Ferreira AS. Occult hepati tis B in patients on hemodialysis: a review[J], Ann Hepato l, 2013, 12: 527-531.
-
4Dag lar D, Ergani A, Demirbakan H, et al . Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients[]]. Mikrobiyol Bu1,2014,48:143-150,.
-
5Hinrichsen H, Leimenstoll G, Stegen G, et al . Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a mul ticentre study in 2796 patients[]]. Gut,2002,51:429-433.
-
6Cartilho F], Moraes CR,Pinho ]R, et al. Hepatitis B virus infection in Haemodialysis Centres from Santa Catarina State, Southern BraziL Predictive risk factors for infection and molecular epidemiology[J]. BMC Public Health, 2004, 27:13-23,.
-
7Launay 0, van der Vliet D, Rosenberg AR, et al. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults wi th HIV- 1: a randomized controlled trial[]]. ]AMA, 2011,305:1432-1440.
-
8Hwang LY, Grimes CZ, Tran TQ, et al. Accelerated hepatitis B vaccination schedule among drJ.1g users: a randomized controlled t.r i al ].] ]. ] Infect Dis, 2010, 202: 1500-1509 .
-
9北京市血液透析登记2012年度报告.乙型肝炎和丙型肝炎感染情况[J].中国血液净化,2012,11(增):26-28.
-
10黄颂敏,陈肖蕾.血液透析中的乙型肝炎病毒感染[J].中国实用内科杂志,2008,28(1):25-27. 被引量:21
引证文献3
-
1李荣山,周芸.血液透析中心乙型肝炎、丙型肝炎的控制[J].中国血液净化,2015,14(3):177-179. 被引量:11
-
2张海莹,饶慧瑛.谁是丙型病毒性肝炎的传染源[J].中国血液净化,2017,16(10):657-660.
-
3黎明新,朱明艳,万冰,王睿,马佳.不同方法筛查血液透析人群中丙型肝炎病毒感染结果的比较分析[J].沈阳医学院学报,2017,19(6):469-472. 被引量:4
二级引证文献15
-
1胡艳珍.维持性血液透析患者病毒性肝炎感染预防护理体会[J].中国继续医学教育,2016,8(12):261-262. 被引量:2
-
2王伟.血液透析患者丙肝感染现状分析与护理体会[J].中国现代医生,2016,54(36):152-155.
-
3谭磊,韩瑜,石庆芬.血透病人丙型和戊型肝炎病毒感染及临床意义分析[J].中国农村卫生,2017,9(8):39-39.
-
4张玲.血液透析患者实施丙肝及乙肝预防控制措施的成效探讨[J].中外医疗,2017,36(11):21-23. 被引量:2
-
5杨甲,饶慧瑛.从检验指标判断乙型病毒性肝炎患者的传染性[J].中国血液净化,2017,16(10):664-666. 被引量:3
-
6王凤荣.肝硬化腹水的护理效果观察[J].中国继续医学教育,2017,9(32):130-131. 被引量:4
-
7胡凌峰.血透患者接种乙型肝炎疫苗的疗效观察[J].医学食疗与健康,2019,0(4):164-165.
-
8侯敖雪.核酸检验与酶联免疫检测血液病毒的应用及检验准确率分析[J].中国医药指南,2019,17(25):83-84. 被引量:1
-
9陈群,陈燕芝,何丽.终末期尿毒症血液透析者乙肝和丙肝感染情况调查分析[J].中国地方病防治,2019,34(5):574-574. 被引量:3
-
10陈瑾,洪大情,陈莎莎,李贵森,王莉.艾尔巴韦/格拉瑞韦治疗透析患者1b型丙型肝炎病毒感染的疗效——3例病例报告及文献复习[J].中国感染控制杂志,2020,19(2):143-147. 被引量:4
-
1尹芳.婴幼儿输液反应的临床特点及防治(附7例报告)[J].衡阳医学院学报,1992,20(4):422-423.
-
2李雅立,赵杰.脑血管病住院患者院内感染特点及防治措施[J].中国冶金工业医学杂志,2005,22(6):702-703. 被引量:1
-
3郑聪,金桂芳,陈晓东.ICU内医院感染的特点及防治[J].临床荟萃,2000,15(6):254-255. 被引量:16
-
4顾艳.血液透析并发颅内出血临床分析及护理[J].中外医学研究,2010,8(22):115-115. 被引量:2
-
5黄刚,王燕.老年人输液反应特点及防治的探讨[J].石河子医学院学报,1997,19(1):20-21. 被引量:1
-
6卢瑛.患者感染死亡的临床特点及防治措施研究[J].中国社区医师,2016,32(22):73-74.
-
7杨兴奎,王军,王小峰.老年脑出血术后并发多器官衰竭160例临床研究[J].陕西医学杂志,2009,38(8):1085-1086. 被引量:4
-
8万苏闽,陈叶香.新生儿医院感染临床特点与防治[J].中华现代护理杂志,2006,12(29):2821-2822. 被引量:4
-
9姚于泓,许平辉,池小凤,张晓莺.维持性血液透析并发心房纤颤11例临床分析[J].实用医学杂志,2007,23(9):1358-1359. 被引量:2
-
10陈艳曙.老年糖尿病低血糖特点及防治[J].全科护理,2011,9(4):355-357. 被引量:5